TC BioPharm (Holdings) PLC (TCBP)
2.04
+0.58
(+39.73%)
USD |
NASDAQ |
May 06, 09:35
TC BioPharm Price: 2.04 for May 6, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 1.55 | 1.55 | 1.402 | 1.46 | 45061.00 |
May 02, 2024 | 1.47 | 1.49 | 1.43 | 1.45 | 45792.00 |
May 01, 2024 | 1.43 | 1.524 | 1.43 | 1.48 | 52160.00 |
Apr 30, 2024 | 1.49 | 1.54 | 1.40 | 1.43 | 55981.00 |
Apr 29, 2024 | 1.60 | 1.60 | 1.49 | 1.49 | 67310.00 |
Apr 26, 2024 | 1.58 | 1.63 | 1.51 | 1.53 | 71794.00 |
Apr 25, 2024 | 1.52 | 1.65 | 1.482 | 1.57 | 143462.0 |
Apr 24, 2024 | 1.55 | 1.62 | 1.44 | 1.47 | 114078.0 |
Apr 23, 2024 | 1.55 | 1.67 | 1.54 | 1.58 | 113576.0 |
Apr 22, 2024 | 1.50 | 1.600 | 1.49 | 1.58 | 145337.0 |
Apr 19, 2024 | 1.49 | 1.49 | 1.38 | 1.479 | 85893.00 |
Apr 18, 2024 | 1.38 | 1.52 | 1.374 | 1.42 | 175118.0 |
Apr 17, 2024 | 1.38 | 1.393 | 1.30 | 1.35 | 76014.00 |
Apr 16, 2024 | 1.31 | 1.35 | 1.27 | 1.33 | 114214.0 |
Apr 15, 2024 | 1.54 | 1.54 | 1.30 | 1.31 | 370249.0 |
Apr 12, 2024 | 1.75 | 1.75 | 1.61 | 1.61 | 155151.0 |
Apr 11, 2024 | 1.66 | 1.75 | 1.66 | 1.73 | 108462.0 |
Apr 10, 2024 | 1.68 | 1.79 | 1.60 | 1.70 | 318734.0 |
Apr 09, 2024 | 1.72 | 1.98 | 1.64 | 1.86 | 441003.0 |
Apr 08, 2024 | 1.90 | 1.90 | 1.65 | 1.78 | 506938.0 |
Apr 05, 2024 | 1.83 | 2.01 | 1.76 | 1.90 | 1.541M |
Apr 04, 2024 | 2.23 | 3.27 | 1.82 | 1.95 | 87.76M |
Apr 03, 2024 | 1.29 | 1.310 | 1.25 | 1.30 | 152440.0 |
Apr 02, 2024 | 1.24 | 1.33 | 1.24 | 1.27 | 200838.0 |
Apr 01, 2024 | 1.33 | 1.33 | 1.18 | 1.27 | 282131.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.885
Minimum
Feb 05 2024
2120.00
Maximum
Feb 11 2022
251.42
Average
38.75
Median
Price Benchmarks
Adaptimmune Therapeutics PLC | 1.20 |
Biodexa Pharmaceuticals Plc | 1.16 |
NuCana PLC | 4.26 |
Autolus Therapeutics PLC | 4.25 |
Mereo BioPharma Group PLC | 3.32 |
Price Related Metrics
PS Ratio | 0.1369 |
Price to Book Value | 1.905 |
Earnings Yield | -247.9% |
Market Cap | 6.518M |